GH8-16845-99883
3 vaccinations
2 coded responses
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 420 / KY
- Registered
- 2021-07-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-30
Registered in v-safe
-
2021-07-30
Dose 1 — Pfizer-BioNTech
- 2021-07-30
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-13
-
2021-08-20
Dose 2 — Pfizer-BioNTech
-
2021-08-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-08-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-08-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-08-24
-
2021-08-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2021-08-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-27
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-05
-
2021-09-10
Survey response — day 21, dose 2MedDRA: Cough, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, headache, body aches,MedDRA releases: 2024-11 · check-in free text available
-
2021-09-10
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-15
- 2021-09-19
- 2021-09-26
- 2021-10-04
- 2021-11-19
-
2022-04-06
Dose 3 — Pfizer-BioNTech
- 2022-05-04
- 2022-05-18
- 2022-07-06
- 2022-10-06
-
2023-04-08
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, Chills, Cough, Diarrhoea, Headache, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
| 3 | 2022-04-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — day 21, dose 2
Symptoms: Cough, headache, body aches,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release